1. Home
  2. AVR vs BWAY Comparison

AVR vs BWAY Comparison

Compare AVR & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVR
  • BWAY
  • Stock Information
  • Founded
  • AVR 1999
  • BWAY 2003
  • Country
  • AVR Australia
  • BWAY Israel
  • Employees
  • AVR N/A
  • BWAY N/A
  • Industry
  • AVR
  • BWAY Medical/Dental Instruments
  • Sector
  • AVR
  • BWAY Health Care
  • Exchange
  • AVR NYSE
  • BWAY Nasdaq
  • Market Cap
  • AVR 215.6M
  • BWAY 207.4M
  • IPO Year
  • AVR 2024
  • BWAY 2019
  • Fundamental
  • Price
  • AVR $8.25
  • BWAY $10.75
  • Analyst Decision
  • AVR Strong Buy
  • BWAY Strong Buy
  • Analyst Count
  • AVR 4
  • BWAY 3
  • Target Price
  • AVR $16.50
  • BWAY $13.17
  • AVG Volume (30 Days)
  • AVR 109.9K
  • BWAY 72.3K
  • Earning Date
  • AVR 01-01-0001
  • BWAY 03-05-2025
  • Dividend Yield
  • AVR N/A
  • BWAY N/A
  • EPS Growth
  • AVR N/A
  • BWAY N/A
  • EPS
  • AVR N/A
  • BWAY 0.04
  • Revenue
  • AVR $2,826,588.00
  • BWAY $38,631,000.00
  • Revenue This Year
  • AVR N/A
  • BWAY $388.82
  • Revenue Next Year
  • AVR $25.66
  • BWAY $18.70
  • P/E Ratio
  • AVR N/A
  • BWAY $143.24
  • Revenue Growth
  • AVR N/A
  • BWAY 34.19
  • 52 Week Low
  • AVR $5.10
  • BWAY $4.61
  • 52 Week High
  • AVR $8.79
  • BWAY $11.79
  • Technical
  • Relative Strength Index (RSI)
  • AVR N/A
  • BWAY 51.17
  • Support Level
  • AVR N/A
  • BWAY $10.33
  • Resistance Level
  • AVR N/A
  • BWAY $11.79
  • Average True Range (ATR)
  • AVR 0.00
  • BWAY 0.56
  • MACD
  • AVR 0.00
  • BWAY 0.01
  • Stochastic Oscillator
  • AVR 0.00
  • BWAY 46.39

About AVR ANTERIS TECHNOLOGIES GLOBAL CORP

Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: